Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06981351 · ClinicalTrials.gov registry record · NA

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

A NA study of Antisocial Behavior, sponsored by The Mind Research Network.

Recruiting
Registry status
NA
Development phase
288
Enrollment target
1
Study location

NCT06981351: Recruiting NA study of Antisocial Behavior, sponsored by The Mind Research Network.

NCT06981351 is a NA study of Antisocial Behavior that is actively recruiting participants, run by The Mind Research Network. The registered enrollment target is 288 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06981351, a NA study of Antisocial Behavior, is actively recruiting participants, sponsored by The Mind Research Network.

RECRUITING
Registry status
NA
Development phase
288 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target one of two subtypes of antisocial criminal offenders, who are characterized by either: 1) Attention to context-based deficits, or 2) Affective cognitive control-based deficits. The main questions it aims to answer are: Does matching deficit type with targeted cognitive training improve outcomes (relative to mismatched training)? What are the functional brain mechanisms that underlie treatment change? Participants will: Be assigned to cognitive training that either does or does not match their deficit type. Complete six one-hour sessions of cognitive skills training. Complete pre and post-training behavioral tasks assessing self-regulation deficits. Complete structural MRI scans and functional MRI scans assessing cognitive control. Complete post-treatment follow-up assessments evaluating self-regulation, adjustment, and stressful life events, substance use and recidivism.

Primary Outcome

Stroop task. Performance is quantified by number of correct responses (0 - 100)%.

Conditions Studied

Interventions

  • BEHAVIORAL Attention to Context (ATC) training
  • BEHAVIORAL Affective Cognitive Control (ACC) training

Study Locations (1)

New Mexico

  • Mind Research Network/Lovelace Biomedical Research Institute - Albuquerque

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2025-03-18
Est. Completion 2029-05-31
Phase NA
The Mind Research Network

17 total trials

What NCT06981351 shows while recruiting

NCT06981351 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Antisocial Behavior appearing as the primary indexed condition, and to 2 interventions - of which Attention to Context (ATC) training is the first listed.

NCT06981351 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT06981351 about?

NCT06981351 is a clinical study titled "Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders". The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target one of two subtypes ...

What is the current status of trial NCT06981351?

This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2025-03-18. Estimated completion is 2029-05-31.

What conditions does trial NCT06981351 study?

This clinical trial studies the following conditions: Antisocial Behavior.

What interventions are being tested in trial NCT06981351?

The interventions under investigation include: Attention to Context (ATC) training (BEHAVIORAL), Affective Cognitive Control (ACC) training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06981351?

This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06981351 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Antisocial Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06981351's enrollment target sits among peer trials

288 376th of 2000 higher than 1,624 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT04621877 · 288 participants · NA

    Lay-Delivered Behavioral Activation in Senior Centers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06981351, the US trial registry maintained by the National Library of Medicine. NCT06981351 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.